Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biological Psychiatry

• Publication date

  2008-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BIOPSYCH.2007.09.012PMID 18028881PMCID PMC2385784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy for Generalized Anxiety Disorder

  2008cited by this paper
• Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.

  2007cited by this paper
• Cerebral Blood Flow in Immediate and Sustained Anxiety

  2007influential reference
• Decreased N‐acetyl‐aspartate levels in anterior cingulate and hippocampus in subjects with post‐traumatic stress disorder: a proton magnetic resonance spectroscopy study

  2007cited by this paper
• Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

  2007cited by this paper
• Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder.

  2007cited by this paper
• The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders

  2007cited by this paper
• Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression.

  2007cited by this paper
• Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

  2006cited by this paper
• The impact of generalized anxiety disorder and stressful life events on risk for major depressive episodes

  2006cited by this paper
• Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.

  2006cited by this paper
• Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging

  2006influential reference
• Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex.

  2006cited by this paper
• Riluzole promotes cell survival and neurite outgrowth in rat sensory neurones in vitro

  2006cited by this paper
• The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions.

  2006cited by this paper
• A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe

  2006cited by this paper
• Decreased prefrontal Myo-inositol in major depressive disorder.

  2005cited by this paper
• An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.

  2005cited by this paper
• Open-label trial of riluzole in generalized anxiety disorder.

  2005cited by this paper
• Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla

  2005influential reference
• MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter

  2005cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Assessment of glutamate and glutamine contribution to in vivo N‐acetylaspartate quantification in human brain by 1H‐magnetic resonance spectroscopy

  2005cited by this paper
• A Comparative Study of the Different N-Acetylaspartate Measures of the Medial Temporal Lobe in Alzheimer’s Disease

  2005cited by this paper
• Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study.

  2004cited by this paper
• Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures

  2004cited by this paper
• An open-label trial of riluzole in patients with treatment-resistant major depression.

  2004cited by this paper
• Riluzole augmentation for treatment-resistant depression.

  2004cited by this paper
• Screening for generalized anxiety disorder using the Penn State Worry Questionnaire: a receiver operating characteristic analysis.

  2003cited by this paper
• N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function

  2003cited by this paper
• Riluzole enhances expression of brain‐derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus

  2002cited by this paper
• Neuropsychopharmacology : The Fifth Generation of Progress

  2002cited by this paper
• Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder.

  2001cited by this paper
• The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up.

  2001cited by this paper
• Pharmacotherapy of generalized anxiety disorder.

  2001cited by this paper
• Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes.

  2001cited by this paper
• N‐Acetyl Aspartate—A Neuronal Marker?

  2001cited by this paper
• 6 THE DIVERSE ROLES OF L-GLUTAMIC ACID IN BRAIN SIGNAL TRANSDUCTION

  2001cited by this paper
• Riluzole inhibits the persistent sodium current in mammalian CNS neurons

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Anxiety in healthy humans is associated with orbital frontal chemistry

  2000cited by this paper
• The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death.

  2000cited by this paper
• Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

  1999cited by this paper
• In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat‐related posttraumatic stress disorder

  1998cited by this paper
• Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

  1998cited by this paper
• Reproducibility of Proton Magnetic Resonance Spectroscopic Imaging in Patients with Schizophrenia

  1998cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS

  1997cited by this paper
• Quantitative proton MR spectroscopic imaging of the human brain

  1996cited by this paper
• Why Stress Is Bad for Your Brain

  1996cited by this paper
• Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate.

  1994cited by this paper
• Multisection proton MR spectroscopic imaging of the brain.

  1993cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Hippocampal damage associated with prolonged glucocorticoid exposure in primates

  1990cited by this paper
• Development and validation of the Penn State Worry Questionnaire.

  1990cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Transdiagnostic reduction in cortical choline-containing compounds in anxiety disorders: a 1H-magnetic resonance spectroscopy meta-analysis

  2025cites this paper
• Efficacy of glutamate-GABA modulator riluzole for the treatment of cognitive and psychotic symptoms in 22q11.2 deletion syndrome: A placebo-controlled crossover trial.

  2025cites this paper
• Advances in neuroscience research and big data's analysis on anxiety disorder.

  2024cites this paper
• Neuroimaging Insights: Kava’s (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder

  2023cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2021cites this paper
• Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations.

  2020cites this paper
• Current trends in treatment of generalised anxiety disorder

  2020cites this paper
• The effect of sandplay therapy on the thalamus in the treatment of generalized anxiety disorder: A case report.

  2020cites this paper
• Sex differences in brain metabolites in anxiety and mood disorders.

  2020cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2020cites this paper
• Aktuální trendy v léčbě generalizované úzkostné poruchy

  2020cites this paper
• Measurement of Post-Treatment Changes in Brain Metabolites in Patients with Generalized Anxiety Disorder using Magnetic Resonance Spectroscopy

  2020cites this paper
• Novel investigational therapeutics for generalized anxiety disorder (GAD)

  2019cites this paper
• Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTD.

  2018cites this paper
• Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

  2017cites this paper
• UPLC–MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients

  2017cites this paper
• Metabolic alterations in generalised anxiety disorder: a review of proton magnetic resonance spectroscopic studies

  2017influential citation
• Biological markers of generalized anxiety disorder

  2017cites this paper
• Impact of childhood emotional abuse on neocortical neurometabolites and complex emotional processing in patients with generalized anxiety disorder.

  2016cites this paper
• Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study.

  2016cites this paper
• Biochemistry of the cingulate cortex in autism: An MR spectroscopy study

  2016cites this paper
• Working memory dysfunction associated with brain functional deficits and cellular metabolic changes in patients with generalized anxiety disorder.

  2016cites this paper
• Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: Proton magnetic resonance spectroscopy at 3 Tesla

  2015cites this paper
• Anatomical and neurochemical investigation of the brain in autism

  2014cites this paper
• Whole-brain gray matter volume abnormalities in patients with generalized anxiety disorder: voxel-based morphometry

  2014cites this paper
• Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight☆

  2014influential citation
• Glutamate-based anxiolytic ligands in clinical trials

  2013cites this paper
• Treatment of Generalized Anxiety Disorders: Unmet Needs

  2013cites this paper
• White matter integrity alterations in first episode, treatment-naive generalized anxiety disorder.

  2013cites this paper
• Non-Antidepressant Treatment of Generalized Anxiety Disorder.

  2013cites this paper
• New approaches to the pharmacological management of generalized anxiety disorder

  2013cites this paper
• Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders

  2013cites this paper
• A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.

  2013influential citation
• New perspectives in glutamate and anxiety.

  2012cites this paper
• Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models.

  2012cites this paper
• Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.

  2012cites this paper
• The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism

  2012cites this paper
• Essential Evidence-Based Psychopharmacology: Evidence-based pharmacotherapy of generalized anxiety disorder

  2012cites this paper
• Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.

  2011influential citation
• Evidence-based pharmacological treatment of generalized anxiety disorder.

  2011cites this paper
• Advances in pharmacotherapy for pediatric anxiety disorders

  2011cites this paper
• White-matter abnormalities in the right posterior hemisphere in generalized anxiety disorder: a diffusion imaging study

  2011cites this paper
• Contextual conditioning in rats as an animal model for generalized anxiety disorder

  2011cites this paper
• The use of proton magnetic resonance spectroscopy in PTSD research--meta-analyses of findings and methodological review.

  2010cites this paper
• Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

  2010cites this paper
• Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

  2010influential citation
• Neurochemical Alterations in Methamphetamine-Dependent Patients Treated with Cytidine-5′-Diphosphate Choline: A Longitudinal Proton Magnetic Resonance Spectroscopy Study

  2010cites this paper
• Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

  2010influential citation
• Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells.

  2010cites this paper
• Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats.

  2010cites this paper
• A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder

  2010cites this paper
• Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety Disorder

  2009cites this paper
• Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders

  2009cites this paper
• Current status of brain imaging in anxiety disorders

  2009cites this paper
• Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.

  2009cites this paper
• Riluzole in psychiatry: a systematic review of the literature

  2008cites this paper
• Chronic Riluzole Treatment Increases Glucose Metabolism in Rat Prefrontal Cortex and Hippocampus

  2008cites this paper
• Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.

  2008cites this paper
• Current awareness in human psychopharmacology.

  2008cites this paper
• Current awareness in human psychopharmacology

  2008cites this paper
• Early intervention in bipolar disorder, part II: therapeutics

  2008cites this paper
• Riluzole in the Treatment of Mood and Anxiety Disorders

  2008cites this paper